Nanomaterials for theranostics and tissue engineering : (Record no. 82481)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 04994cam a2200577 a 4500 |
| 001 - CONTROL NUMBER | |
| control field | on1190859379 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20230516165905.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m o d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr |n||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 200828s2020 ne o 001 0 eng d |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | YDX |
| Language of cataloging | eng |
| Description conventions | pn |
| Transcribing agency | YDX |
| Modifying agency | OPELS |
| -- | EBLCP |
| -- | UKAHL |
| -- | UKMGB |
| -- | OCLCF |
| -- | OCLCO |
| -- | OCLCQ |
| -- | K6U |
| -- | OCLCQ |
| 015 ## - NATIONAL BIBLIOGRAPHY NUMBER | |
| National bibliography number | GBC0B7107 |
| Source | bnb |
| 016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER | |
| Record control number | 019886921 |
| Source | Uk |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780128178393 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 0128178396 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 9780128178386 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 0128178388 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)1190859379 |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | TA418.9.N35 |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 620.1/15 |
| Edition number | 23 |
| 245 00 - TITLE STATEMENT | |
| Title | Nanomaterials for theranostics and tissue engineering : |
| Remainder of title | techniques, trends and applications / |
| Statement of responsibility, etc. | edited by Filippo Rossi and Alberto Rainer. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | Amsterdam : |
| Name of publisher, distributor, etc. | Elsevier, |
| Date of publication, distribution, etc. | 2020. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 490 1# - SERIES STATEMENT | |
| Series statement | Micro and Nano Technologies |
| 500 ## - GENERAL NOTE | |
| General note | Includes index. |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Front Cover -- Nanomaterials for Theranostics and Tissue Engineering -- Copyright Page -- Contents -- List of contributors -- Introduction -- 1 Polymeric nanoparticles for controlled drug delivery -- 1.1 General concepts and synthetic strategies -- 1.2 Polymer nanoparticles for controlled drug delivery -- 1.2.1 Stimuli-responsive polymer nanoparticles -- 1.3 The long road from the bench to the clinic -- 1.4 Conclusions -- References -- 2 Extracellular vesicles in regenerative medicine -- 2.1 Introduction -- 2.2 Cell-based therapies -- 2.3 Tissue engineering -- 2.4 Cell-free therapies |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 2.4.1 Soluble factors -- 2.4.2 Biogenic and synthetic nanoparticles -- 2.5 Extracellular vesicles in a nutshell -- 2.5.1 Extracellular vesicle biological and physicochemical properties -- 2.5.2 Extracellular vesicle separation and characterization -- 2.5.3 Medical translation of extracellular vesicles -- 2.6 Regenerative properties of extracellular vesicles -- 2.6.1 Why extracellular vesicles? -- 2.6.2 Preclinical studies -- 2.6.3 Clinical studies -- 2.6.4 Limits of extracellular vesicle applications in clinical treatments -- 2.7 Conclusions -- Acknowledgments -- References |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 3 Novel strategies to improve delivery performances -- 3.1 Introduction -- 3.2 Functionalization strategies: the rationale -- 3.2.1 Chemical routes -- 3.2.1.1 Esterification and modification of active ester -- 3.2.1.2 Click chemistry -- 3.2.1.3 Other chemical cross-linking strategies -- 3.2.2 Physical routes -- 3.3 Applications in tissue engineering -- 3.3.1 The cell membranes barrier -- 3.3.2 The tumor environment -- 3.3.3 The blood-brain barrier -- 3.4 Applications in theranostics -- 3.5 Conclusions -- References -- 4 HR-MAS NMR Spectroscopy: novel technologies to measure delivery performance |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 4.1 Introduction -- 4.2 High-resolution magic angle spinning nuclear magnetic resonance -- 4.2.1 Theory -- 4.2.2 Experimental setup -- 4.2.3 Example HR-MAS resolution enhancement in hydrogel polymers and swollen polymers -- 4.3 Pulse field gradient HR-MAS nuclear magnetic resonance spectroscopy -- 4.3.1 Translational motion in isotropic systems -- 4.3.2 Restricted and anisotropic motion -- 4.4 Applications in drug delivery -- 4.4.1 Cyclodextrin nanosponges polymers -- 4.4.2 Agarose-carbomer copolymers hydrogels -- 4.5 Final remarks -- References |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 5 The role of first principles mathematical modeling in the nanomedicine field -- 5.1 The new challenges introduced by nanomedicine -- 5.2 Modeling approaches -- 5.2.1 An introduction to molecular modeling -- 5.2.2 Molecular dynamics -- 5.2.3 Coarse-grained simulations -- 5.2.4 Enhanced sampling methods -- 5.2.5 Macroscale models -- 5.3 Applications of mathematical modeling in the nanomedicine field -- 5.3.1 Biomolecular corona -- 5.3.2 Targeting and cellular uptake -- 5.3.3 Nanoparticle distribution and drug delivery -- 5.4 Conclusions -- References |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Nanostructured materials. |
| 9 (RLIN) | 4537 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Nanomedicine. |
| 9 (RLIN) | 5252 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Tissue engineering. |
| 9 (RLIN) | 3291 |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Nanostructures |
| Authority record control number or standard number | (DNLM)D049329 |
| 9 (RLIN) | 5928 |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Tissue Engineering |
| Authority record control number or standard number | (DNLM)D023822 |
| 9 (RLIN) | 3291 |
| 650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Nanomat�eriaux. |
| Authority record control number or standard number | (CaQQLa)201-0258061 |
| 9 (RLIN) | 68453 |
| 650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | G�enie tissulaire. |
| Authority record control number or standard number | (CaQQLa)201-0392445 |
| 9 (RLIN) | 68656 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Nanomedicine |
| Source of heading or term | fast |
| Authority record control number or standard number | (OCoLC)fst01744350 |
| 9 (RLIN) | 5252 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Nanostructured materials |
| Source of heading or term | fast |
| Authority record control number or standard number | (OCoLC)fst01032630 |
| 9 (RLIN) | 4537 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Tissue engineering |
| Source of heading or term | fast |
| Authority record control number or standard number | (OCoLC)fst01151484 |
| 9 (RLIN) | 3291 |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rossi, Filippo. |
| 9 (RLIN) | 68897 |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rainer, Alberto. |
| 9 (RLIN) | 68898 |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Print version: |
| Title | Nanomaterials for theranostics and tissue engineering. |
| Place, publisher, and date of publication | Amsterdam : Elsevier, 2020 |
| International Standard Book Number | 0128178388 |
| -- | 9780128178386 |
| Record control number | (OCoLC)1122909371 |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
| Uniform title | Micro & nano technologies. |
| 9 (RLIN) | 68899 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Materials specified | ScienceDirect |
| Uniform Resource Identifier | <a href="https://www.sciencedirect.com/science/book/9780128178386">https://www.sciencedirect.com/science/book/9780128178386</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Koha item type | eBooks |
No items available.